Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Billy R Martin

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
European Journal of Pharmacology|December 31, 2002
Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activationNissar A Darmani, Laura J Sim-Selley, Billy R Martin, et al.
Bioorganic & Medicinal Chemistry|October 15, 2010
1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptorJohn W Huffman, Seon A Hepburn, Nataliya Lyutenko, et al.
European Journal of Pharmacology|February 1, 2002
Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigationsMałgorzata Dukat, Imad M Damaj, Richard Young, et al.
Drug and Alcohol Dependence|January 22, 2008
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinolRobert E Vann, Thomas F Gamage, Jonathan A Warner, et al.
Molecular Pharmacology|June 9, 2006
Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administrationLaura J Sim-Selley, Nicole S Schechter, W Kirk Rorrer, et al.
The Journal of Pain|July 24, 2007
Significance of cannabinoid CB1 receptors in improgan antinociceptionNeal C Gehani, Julia W Nalwalk, Raj K Razdan, et al.
Journal of Medicinal Chemistry|October 4, 2002
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analoguesF Ivy Carroll, Jeffrey R Lee, Hernán A Navarro, et al.
Molecular Pharmacology|February 28, 2003
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptorLászló Offertáler, Fong-Ming Mo, Sándor Bátkai, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2002
Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonistsJenny L Wiley, Irina D Beletskaya, Edward W Ng, et al.
European Journal of Pharmacology|January 16, 2002
Assessment of structural commonality between tetrahydrocannabinol and anandamideBilly R Martin, Renee G Jefferson, Ramona Winckler, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
European Journal of Pharmacology|December 31, 2002
Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activationNissar A Darmani, Laura J Sim-Selley, Billy R Martin, et al.
Bioorganic & Medicinal Chemistry|October 15, 2010
1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptorJohn W Huffman, Seon A Hepburn, Nataliya Lyutenko, et al.
European Journal of Pharmacology|February 1, 2002
Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigationsMałgorzata Dukat, Imad M Damaj, Richard Young, et al.
Drug and Alcohol Dependence|January 22, 2008
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinolRobert E Vann, Thomas F Gamage, Jonathan A Warner, et al.
Molecular Pharmacology|June 9, 2006
Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administrationLaura J Sim-Selley, Nicole S Schechter, W Kirk Rorrer, et al.
The Journal of Pain|July 24, 2007
Significance of cannabinoid CB1 receptors in improgan antinociceptionNeal C Gehani, Julia W Nalwalk, Raj K Razdan, et al.
Journal of Medicinal Chemistry|October 4, 2002
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analoguesF Ivy Carroll, Jeffrey R Lee, Hernán A Navarro, et al.
Molecular Pharmacology|February 28, 2003
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptorLászló Offertáler, Fong-Ming Mo, Sándor Bátkai, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2002
Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonistsJenny L Wiley, Irina D Beletskaya, Edward W Ng, et al.
European Journal of Pharmacology|January 16, 2002
Assessment of structural commonality between tetrahydrocannabinol and anandamideBilly R Martin, Renee G Jefferson, Ramona Winckler, et al.
Pageof 11